Design, Synthesis and Biological Evaluation of Some Oxadiazole Derivatives as Novel Amide-Based Inhibitors of Soluble Epoxide Hydrolase
作者:Elham Zavareh、Mahdi Hedayati、Laleh Rad、Azin Kiani、Soraya Shahhosseini、Mehrdad Faizi、Sayyed Tabatabai
DOI:10.2174/1570180811666140220005530
日期:2014.5.31
Soluble epoxide hydrolase (sEH) enzyme plays an important role in the metabolism of endogenous chemical
mediators which are involved in the regulation of blood pressure and inflammation. Although the most reported potent
sEH inhibitors are urea derivatives, these compounds have limited pharmacokinetic profile. In order to improve physicochemical
properties, besides having favorable potency, amide non-urea derivatives with oxadiazole ring as a novel secondary
pharmacophore against sEH enzyme were developed. Most of the novel compounds with appropriate physical properties,
had comparable in vitro sEH inhibitory activity to 12-(3-Adamantan-1-yl-ureido)-dodecanoic acid (AUDA), a potent
urea-based sEH inhibitor. The IC50 value of the most potent compound (15c) was 0.43 nM.
可溶性环氧化物水解酶(sEH)在内源性化学介质的代谢中发挥着重要作用,这些介质参与血压和炎症的调节。尽管目前报道的最有效的sEH抑制剂主要是尿素衍生物,但这些化合物的药代动力学特征有限。为了改善理化特性,除了具有良好的效力外,开发了以噁二唑环作为新型次级药效团的非尿素类酰胺衍生物以针对sEH酶。大多数具有适当物理性质的新化合物在体外的sEH抑制活性与12-(3-氨基-1-基-脲基)-十二酸(AUDA)这一强效尿素类sEH抑制剂相当。最强效化合物(15c)的IC50值为0.43 nM。